MAOA, monoamine oxidase A, 4128

N. diseases: 300; N. variants: 15
Disease: Hepatic Encephalopathy ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0019151
Disease: Hepatic Encephalopathy
Hepatic Encephalopathy 		0.310 Biomarker disease CTD_human Hepatic encephalopathy: An update of pathophysiologic mechanisms. 10564534 1999
CUI: C0019151
Disease: Hepatic Encephalopathy
Hepatic Encephalopathy 		0.310 Biomarker disease CTD_human Alterations of neurotransmitter-related gene expression in human and experimental portal-systemic encephalopathy. 10206825 1998
CUI: C0019151
Disease: Hepatic Encephalopathy
Hepatic Encephalopathy 		0.310 Biomarker disease BEFREE The present findings are therefore not only important for our understanding of the pathophysiology of HE but also extremely relevant to our understanding of the pharmacotherapy of other neuropsychiatric disorders in which biogenic amine and MAO-A dysfunction is indicated. 9048767 1997
CUI: C0019151
Disease: Hepatic Encephalopathy
Hepatic Encephalopathy 		0.310 Biomarker disease CTD_human Increased density of catalytic sites and expression of brain monoamine oxidase A in humans with hepatic encephalopathy. 9048767 1997